H.R. 1020 - Compassionate Freedom of Choice Act of 2017
- Sponsor:
- H. Morgan Griffith
- Summary:
- To allow the manufacture, importation, distribution, and sale of investigational drugs and devices intended for use by terminally ill patients who execute an informed consent document, and for other purposes. (by CRS)
- Status:
- The bill has been referred to committee.
Compassionate Freedom of Choice Act of 2017
H.R. 1020 — 115th Congress (2017–2018)
- Summary
- To allow the manufacture, importation, distribution, and sale of investigational drugs and devices intended for use by terminally ill patients who execute an informed consent document, and for other purposes. (by CRS)
- Learn More
- At OpenCongress
- Title
- To allow the manufacture, importation, distribution, and sale of investigational drugs and devices intended for use by terminally ill patients who execute an informed consent document, and for other purposes.
- Other Titles
- Compassionate Freedom of Choice Act of 2017
- Compassionate Freedom of Choice Act of 2017
- Sponsor
- H. Morgan Griffith
- Co-Sponsors
- Subjects
- Health
- Business records
- Civil actions and liability
- Drug safety, medical device, and laboratory regulation
- Drug therapy
- Health technology, devices, supplies
- Long-term, rehabilitative, and terminal care
- Prescription drugs
- Retail and wholesale trades
- Trade restrictions
- Related Bills
- Major Actions
Introduced 2/13/2017 Referred to Committee - Bill History
-
There have been no votes on this bill.
Action Date Description Introduced 2/13/2017 2/13/2017 Introduced in House 2/13/2017 Referred to the House Committee on Energy and Commerce. 2/17/2017 Referred to the Subcommittee on Health. Number Sponsor Date Offered Status
- chart
- table
Total contributions given to House members from Consumer groups, which…
oppose this bill
Consumer groups | $20,500 |
$20,500 |
Contributions data source: OpenSecrets.org